LITHUANIAN STOUSH OVER DRUG APPROVAL
Government meddling in drug approvals is not an issue only in the US, where foot-dragging over the morning-after pill has landed the Bush Administration in hot water. In Lithuania, the government is defying the European Union, its State Medicines Control Agency, NGOs and several parliamentarians over an anti-cancer drug. The locally- made drug Graslava was sold widely in Eastern Europe before Lithuania joined the EU. It is a less expensive imitation of Amgen’s Neupogen, a product which speeds up the process of white blood cells. However, all other EU countries have banned it, as there are concerns about its safety.
The dispute has become a political hot potato. The deputy head of the State Medicines Control Agency deregistered it, but when the director returned, she reinstated the drug and sacked the deputy. Employees of the agency say that they fear losing their jobs if they oppose the drug.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicideāagain - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Are Dutch doctors too willing to euthanise people with autism and intellectual disability?
Will legalized euthanasia and assisted suicide lead to unnecessary deaths because of an able-ist bias against intellectual disability and autism?...
Euthanasia in Quebec: seamless service at a friendly funeral parlour
In Quebec, the number of cases of euthanasia has risen from 63 in 2015-2016 to 3663 in 2021-2022. Nowadays many...
Against commercial-assisted suicide
The journal Bioethics recently published an attack on commercial assisted suicide (CAS). The author, Yoann Della Croce, condemns it as...
Norway to export sperm
Danish sperm banks have grown into a successful export industry. Now Norway seems to be following the same path. The...
Denmark: parliament pressured to OK euthanasia
A proposal to legalise euthanasia in Denmark has broken the threshold of 50,000 signatures to put it before the Danish...
Australian judges need to review standards for gender dysphoria treatment
Most judges and lawyers in Australia know little about the white-hot debate amongst doctors over appropriate treatment for gender-dysphoric children....